LB
Legend Biotech Corp
🇩🇪XFRA.9LBGermanyHealthcare
€14.70EURdown -0.80 (-5.16%)ClosedEnd of day9:48 PM
Price€14.70-0.80 (-5.16%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US52490G1022
- CUSIP
- Not reported
Company
- Employees
- 3,200
- Headquarters
- Somerset, United States
- Website
- https://legendbiotech.com
- CEO
- Mr. Alan S. Bash
Market
- Shares outstanding
- 194.5M
- Market cap
- €2.86B
Key dates
- Next earnings
- Nov 11, 2026
Highlights
- Market cap
- €3.01B
- EPS LTM
- -$0.47
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.27B+59.54%up year on year
- Net income
- -$91.6M+71.84%up year on year
- Gross margin
- 56.58%-9.5%down year on year
- Free cash flow
- -$255.58M+11.98%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.